…Whether electrosurgery or diathermy will be used. Whether monopolar or bipolar electrocautery is planned. The operative site in relation to the pulse generator and the

…implantation. Beta blockers, particularly non selective agents like nadolol and propranolol, are the first line treatment for reducing arrhythmic risk across all LQTS genotypes. These…

…implantation. Beta blockers, particularly non selective agents like nadolol and propranolol, are the first line treatment for reducing arrhythmic risk across all LQTS genotypes. These…

…The HCM Risk SCD score aims to identify individuals with a high risk of SCD and determine whether an implantable cardioverter defibrillator (ICD) is warranted…

…term prediction of sudden cardiac arrest. The constraint does not lie in therapy: implantable cardioverter defibrillators (ICDs) are highly effective, terminating well over 99% of…

…EPS), and the transition from a purely device based management strategy (implantable cardioverter defibrillators) to one that incorporates pharmacological and interventional (substrate ablation) therapies [5] …

…Pacemakers consist of an implantable pulse generator (IPG) , which contains the electronics, a battery , and one or two leads . The pulse generator generates the electric…

…devices. This section is devoted to artificial pacemakers. More advanced devices (ICD, implantable cardioverter defibrillator; CRT, cardiac resynchronization therapy) are discussed in subsequent chapters. The…

…Use the arm with the higher pressure, or the non dominant arm if the values are equal. Check against a manual measurement and document the…

…A broad spectrum of pharmacologic agents can induce bradycardia or conduction disorders. These include beta blockers, non dihydropyridine calcium channel blockers, antiarrhythmic drugs (amiodarone, dronedarone…